Webcasts

How routinely collected healthcare data can accelerate your real world evidence generation plan efficiently while minimizing burden on sites and patients. During this session you will have the opportunity to learn how secondary data can help address questions asked by different healthcare stakeholders and demonstrate safety, value, and effectiveness of your compound. Live: US: Wednesday, Jun. 10, 2020 10am EDT | 4pm CEST On demand available after airing until Jun. 10, 2021. Register free

What market access looks like now and what’s next – a COVID-19 perspective from IQVIA. Live: Thursday, May 28, 2020, 2020 at 11am EDT On demand available after airing until May 28, 2021. Register free

Learn how breakthrough patient experience strategies can help achieve your study goals in this upcoming webcast. Lead by renowned neuroscientist and behavioral economist Dr. Paul Glimcher, it’s the one webcast this year your team can’t afford to miss. Live: Tuesday, May 19, 2020 at 1pm EDT | 12pm CDT | 10am PDT On demand available after airing until May 19, 2021. Register free

Learn from industry experts how to eliminate compliance risks associated with the up to 65% of sites that lose, never receive, or acknowledge these CDs/DVDs, along with the site audits where findings arise due to data access. Live: Thursday, May 7, 2020 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST On demand available after airing until May 7, 2021.

Learn how the diabetes management space is evolving with new metrics such as Time In Range (TIR), time below range (TBR) and time above range (TAR) growing prominence and the potential benefits that can be achieved by improvements in these metrics Live: Thursday, Mar. 26, 2020 at 11am EDT | 10am PDT | 4pm BST | 5pm CEST On demand available after airing until Mar. 26, 2021. Register free

Patient-facing digital technologies are playing an increasingly important role in clinical trials, to the point where including virtual components in trials has become mainstream. Join Kathy Vandebelt, Global Head of Clinical Innovation at Oracle Health Sciences to discuss where the industry stands on terms like "virtual" or "decentralized" trials, what are the benefits and challenges, and what does the future hold for all of us involved. Live: Thursday, Mar. 12, 2020 at 11am EDT | 8am PDT | 3pm GMT | 4pm CET On demand available after airing until Mar. 12, 2021. Register free

Trying to incorporate data collected from new patient-facing technology into a traditional protocol design and operational practices just won’t work. Join Kathy Vandebelt, Global Head of Clinical Innovation at Oracle Health Sciences to learn ways to optimize data flow in hybrid and decentralized trials to improve patient experience, data quality, and expedite the clinical trial process. Live: Tuesday, Jan. 28, 2020 at 11am EST | 8am PST | 4pm GMT | 5pm CET On demand available after airing until Jan. 28 2021. Register free

Mastering the basics of pharma supply chain order-to-cash management can be a significant driver of product and company success. Cardinal Health 3PL Services shares insights for reducing risk and driving profitability. Live: Wednesday, Nov. 20, 2019 at 10am EST | 9am CST | 3pm GMT | 4pm CET On demand available after airing until Nov. 20, 2020 Register free

As an active global player, Boehringer Ingelheim has digitally transformed critical aspects of their business in order to remain an innovative leader in the life sciences industry. Hear how to gain alignment, coordination, and collaboration across global teams to digitally transform your business one department at a time while navigating complex and evolving mix of global regulations. Live: Wednesday, Nov. 13, 2019 at 2pm EST | 1pm CST | 11am PST On demand available after airing until Nov. 13, 2020 Register free

Japan, the second largest market for branded pharmaceuticals and innovation, is driven in part by Oncology with recent advances in genomic analysis technology. A genetic screening project, LC-SCRUM, conducted by the National Cancer Center, is contributing to the development of multiple novel therapeutics in Japan. Live: Tuesday, Oct. 29, 2019 at 11am JST On demand available after airing until Oct. 29, 2020 Register free

Michael Kleinrock, of The IQVIA Institute for Human Data Science, will moderate a panel of launch and market access experts, as they discuss how biotech companies have addressed some key challenges to achieve launch success. Specific points will include an assessment of the overall outlook, what makes launches excellent, how to determine your optimal strategy, and questions that need to be addressed when deciding whether to launch or to partner. Live: Wednesday, Oct. 23, 2019 at 10am EDT On demand available after airing until Oct. 23, 2020 Register free

Japan, the second largest market for branded pharmaceuticals and innovation, is driven in part by Oncology with recent advances in genomic analysis technology. A genetic screening project, LC-SCRUM, conducted by the National Cancer Center, is contributing to the development of multiple novel therapeutics in Japan. Live: Tuesday, Oct.15, 2019 at 5pm JST and Tuesday, Oct. 29, 2019 at 11am JST On demand available after airing until Oct.15, 2020 and Oct. 29, 2020 Register free

Technology is enabling regulators from organizations of all sizes to process the large amounts of data available to them to make better, faster decisions and take regulatory action where needed and when. Join PharmaExec and Clarivate Analytics on August 14th, 2019 at 12 Noon EST for the webinar: Managing Global Regulatory Complexity: Clinical Trial Transparency, Reporting and Real-Time Data Driven Compliance. Guest Speakers: Robert Paarlberg, Principal of Paarlberg & Associates LLC, a consultancy specializing in global clinical trial disclosure strategy and operations, regulatory policy and regulatory intelligence, Teresa Fishburne, Director & Global Practice Lead, Clinical and Regulatory, Clarivate Analytics and April Hernandez, MSc., Regulatory Consultant, Live: Wednesday, Aug. 14, 2019 at 12pm EDT | 9am PDT | 5pm BST | 6pm CEST On demand available after airing until Aug. 14, 2020. Register free

Amid political and economic turmoil in recent years, and resulting shortcomings in healthcare budget, medical infrastructure, and drug access, the Ukraine government is championing the introduction of an unprecedented set of reforms, prompting a significant evolution in the country's healthcare system.